No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
Acetate |
Acetate |
- |
- |
- |
40件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 70, 71, 73, 75, 76, 78, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 235, 265, 288, 298, 299 |
2 |
Acipimox |
Acipimox |
D07190 |
- |
- |
2件: 78, 265 |
3 |
Acp-001 |
- |
- |
- |
- |
1件: 78 |
4 |
Acp-001 (transcon hgh) |
- |
- |
- |
- |
1件: 78 |
5 |
Aezs-130 (formerly ard-07) |
- |
- |
- |
- |
1件: 78 |
6 |
Albutropin |
- |
- |
- |
- |
1件: 78 |
7 |
Alrn-5281 0.015 mg/kg |
- |
- |
- |
- |
1件: 78 |
8 |
Alrn-5281 0.05 mg/kg |
- |
- |
- |
- |
1件: 78 |
9 |
Alrn-5281 0.15 mg/kg |
- |
- |
- |
- |
1件: 78 |
10 |
Altu-238 |
- |
- |
- |
- |
1件: 78 |
11 |
Amitriptyline |
Amitriptyline |
D00809, D07448 |
2件: SLC6A2, SLC6A4 |
2件: Serotonergic synapse, Synaptic vesicle cycle |
3件: 78, 226, 299 |
12 |
Amitriptyline, fluoxetine and tramadol alone (control group) |
Amitriptyline |
D00809, D07448 |
2件: SLC6A2, SLC6A4 |
2件: Serotonergic synapse, Synaptic vesicle cycle |
1件: 78 |
13 |
Anastrozole |
Anastrozole |
D00960 |
1件: CYP19A1 |
3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
3件: 78, 86, 193 |
14 |
Arginin |
- |
- |
- |
- |
1件: 78 |
15 |
Arginine |
L-arginine |
D02982 |
- |
- |
5件: 67, 78, 113, 251, 299 |
16 |
Aricept |
Donepezil |
D00670, D07869 |
1件: ACHE |
2件: Cholinergic synapse, Glycerophospholipid metabolism |
4件: 6, 13, 78, 124 |
17 |
Arimidex (anastrozole) |
Anastrozole |
D00960 |
1件: CYP19A1 |
3件: Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis |
1件: 78 |
18 |
Arx201 |
Arx201 |
- |
- |
- |
1件: 78 |
19 |
Bplg-003 |
- |
- |
- |
- |
1件: 78 |
20 |
Caffeine |
Caffeine |
D00528, D01453 |
11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
6件: 2, 6, 46, 78, 96, 97 |
21 |
Catapresan |
- |
- |
- |
- |
1件: 78 |
22 |
Chemical conjugate of recombinant human growth hormone (rhgh) and human immunoglobulin g4 fragment (hmc001) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
23 |
Clonidin |
Clonidine |
D00281, D00604 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
1件: 78 |
24 |
Clonidine |
Clonidine |
D00281, D00604 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
2件: 6, 78 |
25 |
Clonidine hcl cf 0,150 mg, tabletten |
Clonidine |
D00281, D00604 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
1件: 78 |
26 |
Clonidine hydrochloride |
Clonidine |
D00281, D00604 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
2件: 6, 78 |
27 |
Corticotropin |
Corticotropin |
D00146 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
7件: 2, 13, 46, 75, 78, 84, 222 |
28 |
Corticotropin releasing hormone |
Corticotropin |
D00146 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
29 |
Daily rhgh |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
30 |
Dextromethorphan |
Dextromethorphan |
D00848, D03742, D03744 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
31 |
Dextromethorphan and caffeine |
Dextromethorphan |
D00848, D03742, D03744 |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
17件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Rap1 signaling pathway, Ras signaling pathway, Systemic lupus erythematosus, cAMP signaling pathway |
1件: 78 |
32 |
Donepezil |
Donepezil |
D00670, D07869 |
1件: ACHE |
2件: Cholinergic synapse, Glycerophospholipid metabolism |
9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 |
33 |
Dose-establishing study 1 niacin 250mg |
Niacin |
D00049 |
- |
- |
1件: 78 |
34 |
Dose-establishing study 1 niacin 500mg |
Niacin |
D00049 |
- |
- |
1件: 78 |
35 |
Dose-establishing study 2 niacin 500mg |
Niacin |
D00049 |
- |
- |
1件: 78 |
36 |
Eutropin |
- |
- |
- |
- |
2件: 78, 193 |
37 |
Experimental: vrs-317 |
- |
- |
- |
- |
1件: 78 |
38 |
Fat diet |
- |
- |
- |
- |
1件: 78 |
39 |
Fluoxetine |
Fluoxetine |
D00326, D00823 |
1件: SLC6A4 |
2件: Serotonergic synapse, Synaptic vesicle cycle |
4件: 13, 17, 78, 86 |
40 |
Gelatin |
Gelatin |
D00115, D06892 |
- |
- |
4件: 47, 78, 97, 269 |
41 |
Genotropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 13, 78, 193 |
42 |
Genotropin (pn-180,307) somatropin |
Somatotropin, Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
43 |
Genotropin 12mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
44 |
Genotropin 5 mg/ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
45 |
Genotropin 5.3mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
46 |
Genotropin mark vii pen |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
47 |
Genotropin miniqu |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
48 |
Genotropin miniquick |
- |
- |
- |
- |
1件: 78 |
49 |
Genotropin miniquick 0.2mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
50 |
Genotropin miniquick 0.4mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
51 |
Genotropin miniquick 0.5 mg, injection |
- |
- |
- |
- |
1件: 78 |
52 |
Genotropin miniquick 0.6mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
53 |
Genotropin miniquick 0.8mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
54 |
Genotropin miniquick 1.0mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
55 |
Genotropin miniquick 1.2mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 74, 75, 78 |
56 |
Genotropin, genotropin miniquick |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
57 |
Genotropin® |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
58 |
Gh substitution |
- |
- |
- |
- |
1件: 78 |
59 |
Ghrelin |
Lenomorelin |
- |
- |
- |
3件: 6, 78, 299 |
60 |
Ghrh |
Somatorelin |
D08523 |
1件: GHRHR |
2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
1件: 78 |
61 |
Glucagon |
Glucagon |
D00116, D02118 |
1件: GCGR |
2件: Glucagon signaling pathway, Neuroactive ligand-receptor interaction |
1件: 78 |
62 |
Growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
11件: 2, 13, 19, 46, 78, 96, 191, 193, 195, 265, 299 |
63 |
Growth hormone (genotonorm® or omnitrope®) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 193 |
64 |
Growth hormone (genotropin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
65 |
Growth hormone (nutropin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
66 |
Growth hormone (somatropin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 2, 78 |
67 |
Growth hormone - lb03002 |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
68 |
Growth hormone administration for 6 months |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
69 |
Growth hormone releasing hormone (ghrh) 1-44 |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
70 |
Growth hormone releasing hormone (ghrh) and arginine |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
71 |
Growth hormone replacement therapy |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
72 |
Growth hormone replacement therapy in growth hormone deficient patients only. |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
73 |
Growth hormone, gh |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
74 |
Growth hormone-releasing hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
75 |
Gx-h9 |
- |
- |
- |
- |
1件: 78 |
76 |
H01ac01 |
- |
- |
- |
- |
1件: 78 |
77 |
Hgh-hyfc, recombinant human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
78 |
Hgh-viaderm™ system (hgh or somatropin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
79 |
Hm10560a |
- |
- |
- |
- |
1件: 78 |
80 |
Human acylated ghrelin |
Lenomorelin |
- |
- |
- |
1件: 78 |
81 |
Human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 78, 193, 265 |
82 |
Human growth hormone (1-134) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
83 |
Human serum albumin |
Human serum albumin |
D05424 |
- |
- |
1件: 78 |
84 |
Human serum albumin (hsa) fused to recombinant human growth hormone (hgh) |
Human serum albumin |
D05424 |
- |
- |
1件: 78 |
85 |
Human serum albumin (hsa) fused to somatropin |
Human serum albumin |
D05424 |
- |
- |
1件: 78 |
86 |
Humatrope |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 274 |
87 |
Hydrocortisone |
Hydrocortisone |
D00088 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
8件: 6, 53, 75, 78, 81, 83, 97, 299 |
88 |
Hydrocortisone takeda, tabletter |
Hydrocortisone |
D00088 |
1件: NR3C1 |
1件: Neuroactive ligand-receptor interaction |
1件: 78 |
89 |
Hydrocortone |
- |
- |
- |
- |
1件: 78 |
90 |
Hydrokortison glostrup 5 mg |
- |
- |
- |
- |
1件: 78 |
91 |
Increlex |
Mecasermin |
D03297, D04870 |
2件: GHR, IGF1R |
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
3件: 65, 78, 96 |
92 |
Increlex 10 mg/ml |
Mecasermin |
D03297, D04870 |
2件: GHR, IGF1R |
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
1件: 78 |
93 |
Insulin |
- |
- |
- |
- |
5件: 13, 46, 75, 78, 299 |
94 |
Jintropin aq |
- |
- |
- |
- |
1件: 78 |
95 |
L-arg |
L-arginine |
D02982 |
- |
- |
1件: 78 |
96 |
L-arg+ghrh |
L-arginine |
D02982 |
- |
- |
1件: 78 |
97 |
L-arginine |
L-arginine |
D02982 |
- |
- |
4件: 67, 78, 113, 299 |
98 |
Lb03002 |
- |
- |
- |
- |
1件: 78 |
99 |
Levothyroxine |
Levothyroxine |
D01010, D08125 |
2件: THRA, THRB |
2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
2件: 49, 78 |
100 |
Macimorelin |
Macimorelin |
D10563 |
1件: GHSR |
3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
101 |
Macimorelin acetate |
Macimorelin |
D10563 |
1件: GHSR |
3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
102 |
Macrilen |
Macimorelin |
D10563 |
1件: GHSR |
3件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
103 |
Mecasermin |
Mecasermin |
D03297, D04870 |
2件: GHR, IGF1R |
33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
5件: 78, 96, 168, 265, 299 |
104 |
Mod-4023 |
- |
- |
- |
- |
1件: 78 |
105 |
Mod-4023 (long-acting modified r-hgh) |
- |
- |
- |
- |
1件: 78 |
106 |
Niacin |
Niacin |
D00049 |
- |
- |
3件: 6, 78, 265 |
107 |
Niacin first |
Niacin |
D00049 |
- |
- |
1件: 78 |
108 |
Nn8630 |
- |
- |
- |
- |
1件: 78 |
109 |
Nnc 126-0083 |
- |
- |
- |
- |
1件: 78 |
110 |
Nnc0195-0092 |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
111 |
Nnc0195-0092 10 mg/1.5 ml pds290-10 |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
112 |
Nnc0195-0092 15 mg/1.5 ml pds290-15 |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
113 |
Nnc0195-0092 5 mg/1.5 ml pds290-10 |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
114 |
Nnc0195-0092 dp 6.7 mg ml 3 ml cartridge |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
115 |
Nnc0195-0092 pds290 10 mg-1.5 ml |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
116 |
Nnc0195-0092 pds290 10 mg/1.5 ml |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
117 |
None |
- |
- |
- |
- |
8件: 46, 78, 84, 96, 160, 161, 171, 299 |
118 |
Norditropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
119 |
Norditropin flexpro 10 mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
120 |
Norditropin flexpro 10 mg/1.5 ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
121 |
Norditropin growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
122 |
Norditropin nordiflex® |
- |
- |
- |
- |
1件: 78 |
123 |
Norditropin nordiflex® 10 mg/1.5 ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
124 |
Norditropin nordiflex® 10mg/1.5 ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
125 |
Norditropin simplex |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
126 |
Norditropin simplexx |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
4件: 3, 78, 193, 195 |
127 |
Norditropin simplexx (5mg/1,5 ml) (inn:somatropin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
128 |
Norditropin simplexx (growth hormone) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
129 |
Norditropin simplexx 10 mg |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
130 |
Norditropin simplexx 5mg/1.5ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
131 |
Norditropin® |
- |
- |
- |
- |
1件: 78 |
132 |
Norditropin® flexpro® |
- |
- |
- |
- |
1件: 78 |
133 |
Norditropin® flexpro® pen |
- |
- |
- |
- |
1件: 78 |
134 |
Nutritional supplementation standardized formula |
- |
- |
- |
- |
1件: 78 |
135 |
Nutropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 274 |
136 |
Nutropin aq |
- |
- |
- |
- |
4件: 78, 134, 193, 299 |
137 |
Nutropinaq |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
138 |
Nutropinaq 10 mg/2 ml |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
139 |
Nutropinaq 10 mg/2 ml (30 ui) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
140 |
Oestrogen |
- |
- |
- |
- |
1件: 78 |
141 |
Omnitrope |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 193 |
142 |
Omnitrope® |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
143 |
Once daily subcutaneous injection of genotropin |
- |
- |
- |
- |
1件: 78 |
144 |
Once weekly subcutaneous injection of transcon hgh |
- |
- |
- |
- |
1件: 78 |
145 |
Peg-somatropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
146 |
Pegvisomant |
Pegvisomant |
D05394 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
147 |
Pegylated polypeptide hormone of human recombinant origin peg-hgh |
- |
- |
- |
- |
1件: 78 |
148 |
Pegylated recombinant human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
149 |
Pegylated somatropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
150 |
Pha-794,428 |
- |
- |
- |
- |
1件: 78 |
151 |
Pha-794428 |
- |
- |
- |
- |
1件: 78 |
152 |
Phosphate |
Phosphate ion |
- |
- |
- |
29件: 2, 3, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 283, 284, 285, 286, 299 |
153 |
Phosphate sandoz |
Phosphate ion |
- |
- |
- |
1件: 78 |
154 |
Pioglitazone |
Pioglitazone |
D00945, D08378 |
1件: PPARG |
9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
155 |
Plenadren 20 mg modified-release tablets |
- |
- |
- |
- |
1件: 78 |
156 |
Plenadren 5 mg modified-release tablets |
- |
- |
- |
- |
1件: 78 |
157 |
Pn-180307 |
- |
- |
- |
- |
1件: 78 |
158 |
R-hgh |
- |
- |
- |
- |
1件: 78 |
159 |
R-hgh freeze-dried |
- |
- |
- |
- |
1件: 78 |
160 |
R-hgh liquid (saizen) |
- |
- |
- |
- |
1件: 78 |
161 |
Recombinanat dna-derived human growth |
- |
- |
- |
- |
1件: 78 |
162 |
Recombinanat dna-derived human growth hormone produced in e.coli |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
163 |
Recombinant dna-derived human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
164 |
Recombinant dna-derived human growth hormone produced in e.coli |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
165 |
Recombinant growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 96 |
166 |
Recombinant growth hormone, genotropin (pfizer) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
167 |
Recombinant human gowth hormone |
- |
- |
- |
- |
1件: 78 |
168 |
Recombinant human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
3件: 78, 193, 265 |
169 |
Recombinant human growth hormone (genotropin® ) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
170 |
Recombinant human growth hormone (r-hgh) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
171 |
Recombinant human growth hormone (rhgh) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
172 |
Recombinant human growth hormone(rhgh) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
173 |
Recombinant human igf-1 |
- |
- |
- |
- |
2件: 78, 299 |
174 |
Recombinant human serum albumin (hsa) fused to human growth hormone (hgh) |
Human serum albumin |
D05424 |
- |
- |
1件: 78 |
175 |
Recombinant human somatotropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 236 |
176 |
Recombinat human growth hormone |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
177 |
Regular insulin |
- |
- |
- |
- |
1件: 78 |
178 |
Rhgh |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 96 |
179 |
Routine transdermal oestrogen patch |
- |
- |
- |
- |
1件: 78 |
180 |
Rvg 15790 or rvg 25480 |
- |
- |
- |
- |
1件: 78 |
181 |
Saizen |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
182 |
Saizen 8mg click.easy powder for solution for injection |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
183 |
Saizen® |
- |
- |
- |
- |
1件: 78 |
184 |
Saline |
Sodium chloride |
D02056 |
- |
- |
10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
185 |
Sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group) |
Amitriptyline |
D00809, D07448 |
2件: SLC6A2, SLC6A4 |
2件: Serotonergic synapse, Synaptic vesicle cycle |
1件: 78 |
186 |
Serum albumin |
Human serum albumin |
D05424 |
- |
- |
1件: 78 |
187 |
Somapacitan |
Somapacitan |
D11194 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
188 |
Somatorelin |
Somatorelin |
D08523 |
1件: GHRHR |
2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
2件: 13, 78 |
189 |
Somatostatin |
Somatostatin |
D07431 |
5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 |
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
2件: 67, 78 |
190 |
Somatotropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
2件: 78, 236 |
191 |
Somatotropine |
- |
- |
- |
- |
1件: 78 |
192 |
Somatrogon |
Somatrogon |
D10990 |
- |
- |
1件: 78 |
193 |
Somatropin |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
15件: 2, 3, 19, 46, 74, 75, 78, 96, 113, 193, 195, 265, 274, 276, 299 |
194 |
Somatropin (rdna origin) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
195 |
Somatropin aq |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
196 |
Somatropin for injection |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
197 |
Somatropin injection |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
198 |
Somatropine |
- |
- |
- |
- |
1件: 78 |
199 |
Somavaratan |
Somavaratan |
D11193 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
200 |
Somavaratan (vrs-317) |
Somavaratan |
D11193 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
201 |
Strontium ranelate |
Strontium ranelate |
D08468 |
- |
- |
1件: 78 |
202 |
Sustained-release recombinant human gh (sr-rhgh) |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |
203 |
Synacthen |
- |
- |
- |
- |
1件: 78 |
204 |
Synacthen (tetracosactrin) |
Tetracosactide |
D00284 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
205 |
Syntropin |
- |
- |
- |
- |
1件: 78 |
206 |
Tesamorelin |
Tesamorelin |
D06655, D09015 |
1件: GHRHR |
2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction |
2件: 78, 265 |
207 |
Testogel |
- |
- |
- |
- |
1件: 78 |
208 |
Testosterone |
Testosterone |
D00075, D00957, D00958, D00959, D06085, D06087 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
7件: 1, 2, 3, 13, 78, 113, 265 |
209 |
Testosterone plus somatropin |
Testosterone |
D00075, D00957, D00958, D00959, D06085, D06087 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
1件: 78 |
210 |
Tetracosactrin |
Tetracosactide |
D00284 |
1件: MC2R |
5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
1件: 78 |
211 |
Theraderm |
Levomenthol |
D00064 |
2件: TRPA1, TRPM8 |
1件: Inflammatory mediator regulation of TRP channels |
1件: 78 |
212 |
Thyroxin, triiodothyronine |
Liothyronine |
D01011, D08128 |
2件: THRA, THRB |
2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
1件: 78 |
213 |
Tramadol |
Tramadol |
D01355, D08623 |
1件: OPRM1 |
3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
5件: 46, 70, 78, 226, 271 |
214 |
Transcon hgh |
- |
- |
- |
- |
1件: 78 |
215 |
Transdermal testosterone gel |
Testosterone |
D00075, D00957, D00958, D00959, D06085, D06087 |
1件: AR |
3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
1件: 78 |
216 |
Transiently pegylated hgh prodrug |
- |
- |
- |
- |
1件: 78 |
217 |
Triiodothyronine |
Liothyronine |
D01011, D08128 |
2件: THRA, THRB |
2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway |
1件: 78 |
218 |
Trisequens |
- |
- |
- |
- |
1件: 78 |
219 |
Tv-1106 |
- |
- |
- |
- |
1件: 78 |
220 |
Tv1106 |
- |
- |
- |
- |
1件: 78 |
221 |
Vrs-317 |
- |
- |
- |
- |
1件: 78 |
222 |
Zomacton |
Somatotropin |
D02691 |
1件: GHR |
5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
1件: 78 |